Home » Optimer Pockets $68 Million From Astellas for Rights to Antibiotic in Europe
Optimer Pockets $68 Million From Astellas for Rights to Antibiotic in Europe
San Diego-based Optimer Pharmaceuticals has found a partner to help market its most important drug candidate outside the U.S.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May